Leal Therapeutics
Leal Therapeutics is a biotechnology company developing novel therapeutics for patients with central nervous system (CNS) disorders. Their lead programs focus on antisense oligonucleotide (ASO) and small molecule therapeutics targeting metabolic pathways dysregulated in ALS and schizophrenia. The company aims to provide better treatment options for neurodegenerative and neuropsychiatric disorders.
Funding Round:
Funding Amount: $45M
Date: 30-Oct-2024
Investors: Newpath Partners, Chugai Venture Fund, Alexandria Venture Investments, OrbiMed, Euclidean Capital, PhiFund
Markets: Biotechnology, Pharmaceuticals, Healthtech
HQ: Worcester, Massachusetts, United States
Founded: 2021
Website: https://lealtx.com/
LinkedIn: https://www.linkedin.com/company/leal-therapeutics
Crunchbase: https://www.crunchbase.com/organization/leal-therapeutics
Leave a Comment
Comments
No comments yet.